Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1KAN1 | ISIN: CA48265Y1043 | Ticker-Symbol:
Branche
Holz/Papier
Aktienmarkt
Sonstige
1-Jahres-Chart
KP TISSUE INC Chart 1 Jahr
5-Tage-Chart
KP TISSUE INC 5-Tage-Chart
GlobeNewswire (Europe)
47 Leser
Artikel bewerten:
(0)

KP Tissue Inc.: KP Tissue Releases Third Quarter 2024 Financial Results

Finanznachrichten News

MISSISSAUGA, Ontario, Nov. 13, 2024 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q3 2024 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and BonterraTM) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 12.6% interest in Kruger Products.

Kruger Products Q3 2024 Business and Financial Highlights

  • Revenue was $521.1 million in Q3 2024 compared to $473.4 million in Q3 2023, an increase of $47.7 million or 10.1%.
  • Adjusted EBITDA1 was $65.7 million in Q3 2024, compared to $72.4 million in Q3 2023, a decrease of 9.3%.
  • Net income was $18.0 million in Q3 2024 compared to $12.9 million in Q3 2023, an increase of $5.1 million.
  • Declared a quarterly dividend of $0.18 per share to be paid on January 15, 2025.

"Our business continued to perform well with double-digit revenue growth in the third quarter of 2024 on the strength of higher sales volume and favourable selling prices across our North American network," stated KP Tissue's Chief Executive Officer, Dino Bianco. "Despite higher pulp prices and other manufacturing costs year-over-year, we generated solid Adjusted EBITDA of $65.7 million that was within our expectations. In the Consumer segment, we maintained strong revenue momentum through ongoing investments in innovation and brand support. The resulting impact has been highly encouraging with our leadership position rising above 44% in the Canadian facial tissue market, combined with share gains in the bathroom tissue and paper towel categories on a year-over-year basis. On the Away-from-Home front, sales volume slightly improved in the third quarter of 2024 compared to the same period in 2023, while profitability was tempered by additional outsourcing activity."

"The operational highlight of the quarter was the completed construction of our manufacturing plant in Sherbrooke, including the successful start-up of our LDC paper machine with added capacity of 60,000 metric tons. At maturity, the entire Sherbrooke site, which also contains the existing TAD facility along with recently deployed LDC facial tissue and bathroom tissue lines, will produce more than 130,000 metric tons of high-quality tissue products. As a result, we are fulfilling our vision of making Sherbrooke a major hub for tissue manufacturing, enabling additional share gains in North America and reducing our need for purchased paper," Mr. Bianco added.

Outlook for Q4 2024
For the last quarter of 2024, we expect Adjusted EBITDA1 to be in the range of Q3 2024.

Kruger Products Q3 2024 Financial Results
Revenue was $521.1 million in Q3 2024 compared to $473.4 million in Q3 2023, an increase of $47.7 million or 10.1%. The increase in revenue was primarily due to higher sales volume and favourable selling prices across both segments. Revenue was also favourably impacted by foreign exchange fluctuations on U.S. dollar sales.

Cost of sales was $437.3 million in Q3 2024 compared to $386.3 million in Q3 2023, an increase of $51.0 million or 13.2%. The increase in cost of sales was primarily due to higher sales volume and pulp prices, additional outsourcing activity compared to Q3 2023 and the unfavourable impact of foreign exchange fluctuations on U.S. dollar costs, partially offset by lower manufacturing overhead costs due primarily to overhead cost absorption resulting from higher inventory levels in the quarter. Freight rates were higher compared to Q3 2023, while warehousing costs increased slightly as a result of handling costs related to higher sales volume. As a percentage of revenue, cost of sales was 83.9% in Q3 2024 compared to 81.6% in Q3 2023.

Selling, general and administrative (SG&A) expenses were $46.5 million in Q3 2024 compared to $40.0 million in Q3 2023, an increase of $6.5 million or 16.3%. The increase was primarily due to additional investment in advertising and promotion, consulting and legal costs to support operational and corporate initiatives, higher selling expense to primarily support additional sales volume, higher IT spend and foreign exchange losses in Q3 2024 compared to gains in the year ago quarter. As a percentage of revenue, SG&A expenses were 8.9% in Q3 2024 compared to 8.4% in Q3 2023.

Adjusted EBITDA1 was $65.7 million in Q3 2024 compared to $72.4 million in Q3 2023, a decrease of $6.7 million or 9.3%. The decrease was primarily due to higher pulp prices and other manufacturing costs as described above, along with higher freight rates and SG&A expenses, partially offset by higher sales volumes and selling prices along with lower manufacturing overhead costs.

Net income was $18.0 million in Q3 2024 compared to $12.9 million in Q3 2023, an increase of $5.1 million. The increase was primarily due to a higher foreign exchange gain and lower income tax expense, partially offset by lower Adjusted EBITDA1, higher depreciation expense and higher interest expense and other finance costs.

Kruger Products Q3 2024 Financing Activity and Liquidity
On November 1, 2024, Kruger Products issued $135 million in an aggregate principal amount of 6.625% Senior Unsecured Notes (the Notes) due November 1, 2031 through a private placement. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing on May 1, 2025. The majority of the proceeds were used to redeem the $125 million Senior Unsecured Notes with the remainder being used for general corporate purposes.

Kruger Products completed the previously announced redemption of its outstanding $125 million principal amount of 6.0% Senior Unsecured Notes on November 12, 2024 at a redemption price of 100% of the principal amount plus accrued and unpaid interest.

Total liquidity, representing cash and availability under the revolving credit agreements, was $434.2 million as of September 30, 2024. In addition, $14.6 million of cash was held for the Sherbrooke Expansion Project.

KPT Q3 2024 Financial Results
KPT had net income of $2.1 million in Q3 2024. Included in net income was $2.3 million representing KPT's share of Kruger Products' net income, a dilution gain of $0.1 million and depreciation expense of $0.3 million related to adjustments to carrying amounts on acquisition.

Dividends on Common Shares
The Board of Directors of KPT declared a quarterly dividend of $0.18 per share to be paid on January 15, 2025 to shareholders of record at the close of business on December 31, 2024.

Additional Information
For additional information please refer to Management's Discussion and Analysis (MD&A) of KPT and Kruger Products for the third quarter ended September 30, 2024 available on SEDAR+ at www.sedarplus.ca or our website at www.kptissueinc.com.

Third Quarter Results Conference Call Information
KPT will hold its third quarter conference call on Wednesday, November 13, 2024 at 8:30 a.m. Eastern Time.

Via telephone: 1-888-510-2154 or 437-900-0527

Via the internet at: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

A rebroadcast of the conference call will be available until midnight, November 20, 2024 by dialing 1-888-660-6345 or 289-819-1450 and entering passcode 96818.

The replay of the webcast will remain available on the website until midnight, November 20, 2024.

About KP Tissue Inc.
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12.6% interest in Kruger Products. For more information visit www.kptissueinc.com.

About Kruger Products Inc.
Kruger Products is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. Kruger Products serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and BonterraTM. In the U.S., Kruger Products manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. Kruger Products has approximately 3,000 employees and operates nine FSC® COC-certified (FSC® C-104904) production facilities in North America. For more information visit www.krugerproducts.ca.

Non-GAAP Financial Measures
This press release uses certain non-GAAP financial measures which Kruger Products believes provide useful information to management of Kruger Products and the readers of the financial information in measuring the financial performance and financial condition of Kruger Products. These measures do not have a standardized meaning prescribed by GAAP and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Adjusted EBITDA is not a measurement of operating performance computed in accordance with GAAP and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with GAAP. "Adjusted EBITDA" is calculated by Kruger Products as net income (loss) before (i) interest expense and other finance costs, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) loss on sale of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) foreign exchange loss (gain), (viii) costs related to restructuring activities and (ix) changes in amortized cost of Partnership units liability. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the Segment and Geographic Results table of this news release.

Forward-Looking Statements
Certain statements in this press release about KPT's and Kruger Products' current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking statements are based on certain key expectations and assumptions made by KPT or Kruger Products, including the moderation of inflationary pressure on input costs and continued inflationary pressure on SG&A as labour, marketing and IT costs continue to rise. Although KPT and Kruger Products believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking statements since no assurance can be given that such expectations and assumptions will prove to be correct.

The outlook provided in respect of Adjusted EBITDA1 for Q4 2024 is forward-looking information and is based on the assumptions and subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management's expectations, at the date of this press release, regarding Kruger Products' future financial performance. Readers are cautioned that this information may not be appropriate for other purposes.

Many factors could cause Kruger Products' actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from KPT's economic interest in Kruger Products), to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the "Risk Factors - Risks Related to Kruger Products' Business" section of the KPT Annual Information Form dated March 7, 2024 available on SEDAR+ at www.sedarplus.ca Kruger Inc.'s influence over Kruger Products; Kruger Products' reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the ownership of the TAD Sherbrooke Project; risks associated with the operation of the TAD Sherbrooke Project; risks associated with the Sherbrooke Expansion Project; operational risks; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; Kruger Products' inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of Kruger Products or Kruger Products' brands; Kruger Products' sales being less than anticipated; Kruger Products' failure to implement its business and operating strategies; Kruger Products' obligation to make regular capital expenditures; Kruger Products entering into unsuccessful acquisitions; Kruger Products' dependence on key personnel; Kruger Products' inability to retain its existing customers or obtain new customers; Kruger Products' loss of key suppliers; Kruger Products' failure to adequately protect its intellectual property rights; Kruger Products' reliance on third party intellectual property licenses; adverse litigation and other claims affecting Kruger Products; material expenditures due to comprehensive environmental regulation affecting Kruger Products' cash flow; Kruger Products' pension obligations are significant and can be materially higher than predicted if Kruger Products Management's underlying assumptions are incorrect; labour disputes adversely affecting Kruger Products' cost structure and Kruger Products' ability to run its plants; exchange rate and U.S. competitors; Kruger Products' inability to service all of its indebtedness; exposure to potential consumer product liability; covenant compliance; interest rate and refinancing risk; and risks relating to information technology; cyber-security; insurance; internal controls; and trade.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

INFORMATION:
Francois Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
905-812-6936
francois.paroyan@krugerproducts.ca

INVESTORS:
Doris Grbic
Director, Investor Relations
KP Tissue Inc.
437-882-2596
IR@krugerproducts.ca

1 Adjusted EBITDA is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures section of this news release for more information on these measures

Kruger Products Inc.
Unaudited Condensed Consolidated Statements of Financial Position
(thousands of Canadian dollars)
September 30, 2024 December 31, 2023
$ $
Assets
Current assets
Cash and cash equivalents111,215 135,728
Restricted cash44,832 12,451
Trade and other receivables142,468 130,157
Receivables from related parties80 842
Inventories262,343 254,372
Income tax recoverable9,384 4,578
Prepaid expenses13,998 4,726
584,320 542,854
Non-current assets
Property, plant and equipment1,473,638 1,421,650
Right-of-use assets149,445 84,866
Other long-term assets52 3,808
Pensions89,109 69,839
Goodwill152,021 152,021
Intangible assets40,973 26,852
Deferred income taxes5,679 23,740
Total assets2,495,237 2,325,630
Liabilities
Current liabilities
Trade and other payables353,616 400,385
Payables to related parties14,364 10,973
Income tax payable40 -
Dividends payable14,173 13,675
Current portion of long-term debt169,918 35,229
Current portion of lease liabilities39,774 27,154
Current portion of long-term payable to related party5,800 5,800
Current portion of provisions3,728 3,952
601,413 497,168
Non-current liabilities
Long-term debt997,478 1,034,016
Long-term lease liabilities127,194 71,865
Long-term payable to related party31,411 35,580
Long-term provisions6,015 5,740
Pensions14,692 18,935
Post-retirement benefits50,038 48,699
Total liabilities1,828,241 1,712,003
Equity
Share capital302,328 278,252
Contributed surplus395,382 395,382
Deficit(147,962) (164,029)
Accumulated other comprehensive income85,640 81,011
Equity attributable to Kruger Products635,388 590,616
Non-controlling interest31,608 23,011
Total equity666,996 613,627
Total equity and liabilities2,495,237 2,325,630
Kruger Products Inc.
Unaudited Condensed Consolidated Statements of Income (Loss)
(thousands of Canadian dollars)
3-month
period ended
September 30, 2024
3-month
period ended
September 30, 2023
9-month
period ended
September 30, 2024
9-month
period ended
September 30, 2023
$ $ $ $
Revenue 521,085 473,399 1,510,317 1,390,693
Expenses
Cost of sales437,202 386,375 1,262,433 1,171,111
Selling, general and administrative expenses46,533 39,973 133,145 116,890
Restructuring costs, net- 77 219 1,300
Operating income 37,350 46,974 114,520 101,392
Interest expense and other finance costs17,997 16,677 51,132 51,740
Other expense (income)(5,266) 8,395 7,152 (870)
Income before income taxes24,619 21,902 56,236 50,522
Current tax expense1,768 515 3,149 1,943
Deferred tax expense3,244 6,553 11,723 68,860
Income tax expense5,012 7,068 14,872 70,803
Net income (loss) including non-controlling interest19,607 14,834 41,364 (20,281)
Net income attributable to non-controlling interest1,614 1,906 3,823 1,568
Net income (loss) attributable to Kruger Products17,993 12,928 37,541 (21,849)
Kruger Products Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
(thousands of Canadian dollars)
3-month
period ended
September 30, 2024
3-month
period ended
September 30, 2023
9-month
period ended
September 30, 2024
9-month
period ended
September 30, 2023
$ $ $ $
Cash flows from (used in) operating activities
Net income (loss) including non-controlling interest19,607 14,834 41,364 (20,281)
Items not affecting cash
Depreciation26,561 24,227 78,688 70,305
Amortization1,739 1,110 4,300 3,271
Loss (gain) on sale of property, plant and equipment- (11) 269 1,098
Gain on disposal of leased assets- - - (488)
Foreign exchange loss (gain)(5,266) 8,395 8,033 (870)
Interest expense and other finance costs17,997 16,677 51,132 51,740
Pension and post-retirement benefits3,680 2,344 8,964 6,456
Provisions1,297 765 3,415 2,704
Income tax expense5,012 7,068 14,872 70,803
Loss on sale of non-financial assets15 5 27 21
Total items not affecting cash51,035 60,580 169,700 205,040
Net change in non-cash working capital(7,287) 47,409 (52,974) 64,267
Contributions to pension and post-retirement benefit plans(1,154) (2,241) (3,418) (7,439)
Provisions paid- (169) (3,695) (3,443)
Income tax payments, net(680) (550) (3,121) (2,008)
Net cash from operating activities61,521 119,863 147,856 236,136
Cash flows from (used in) investing activities
Purchases of property, plant and equipment(7,857) (5,993) (15,821) (14,673)
Purchases of property, plant and equipment and software
related to the TAD Sherbrooke Project- (837) - (1,580)
Purchases of property, plant and equipment related to the
Sherbrooke Expansion Project(26,740) (21,535) (116,167) (89,995)
Interest paid on credit facilities related to the Sherbrooke Expansion
Project(2,347) (105) (5,136) (321)
Government assistance received- - - 1,250
Purchases of software(7) (48) (294) (556)
Proceeds on sale of property, plant and equipment- 17 28 2,465
Net cash used in investing activities(36,951) (28,501) (137,390) (103,410)
Cash flows from (used in) financing activities
Proceeds from long-term debt5,765 30,761 119,197 87,543
Repayment of long-term debt(11,852) (46,337) (33,045) (69,906)
Payment of deferred financing fees(83) (25) (1,312) (405)
Payment of lease liabilities(9,191) (7,039) (26,463) (20,835)
Change in Restricted cash(1,183) (1,380) (32,381) (3,937)
Interest paid on long-term debt(15,460) (2,921) (38,839) (34,281)
Payment to related party- - (5,800) (5,700)
Dividends paid, net(7,868) (1,741) (17,425) (5,245)
Net cash used in financing activities(39,872) (28,682) (36,068) (52,766)
Effect of exchange rate changes on cash and cash
equivalents held in foreign currency(637) 220 1,089 (76)
Increase (decrease) in cash and cash equivalents during the period(15,939) 62,900 (24,513) 79,884
Cash and cash equivalents - Beginning of period127,154 88,245 135,728 71,261
Cash and cash equivalents - End of period111,215 151,145 111,215 151,145
Kruger Products Inc.
Unaudited Segment and Geographic Results
(thousands of Canadian dollars)
3-month
period ended
September 30, 2024
3-month
period ended
September 30, 2023
9-month
period ended
September 30, 2024
9-month
period ended
September 30, 2023
$ $ $ $
Segment Information
Segment Revenue
Consumer429,196 390,293 1,255,410 1,150,290
AFH91,889 83,106 254,907 240,403
Revenue from external customers521,085 473,399 1,510,317 1,390,693
Adjusted EBITDA
Consumer62,414 65,925 185,373 170,468
AFH6,602 8,381 23,941 15,078
Corporate and other costs(3,351) (1,924) (11,291) (8,159)
Total Adjusted EBITDA65,665 72,382 198,023 177,387
Reconciliation to net income (loss):
Depreciation and amortization28,300 25,337 82,988 73,576
Interest expense and other finance costs17,997 16,677 51,132 51,740
Loss (gain) on sale of property, plant and equipment- (11) 269 1,098
Loss on sale of non-financial assets15 5 27 21
Change in amortized cost of Partnership unit liability- - (881) -
Restructuring costs, net- 77 219 1,300
Foreign exchange loss (gain)(5,266) 8,395 8,033 (870)
Income before income taxes24,619 21,902 56,236 50,522
Income tax expense5,012 7,068 14,872 70,803
Net income (loss) including non-controlling interest19,607 14,834 41,364 (20,281)
Geographic Revenue
Canada282,222 267,588 827,363 793,533
US238,863 205,811 682,954 597,160
Total revenue521,085 473,399 1,510,317 1,390,693
KP Tissue Inc.
Unaudited Condensed Statements of Financial Position
(thousands of Canadian dollars)
September 30, 2024 December 31, 2023
$ $
Assets
Current assets
Dividends receivable1,796 1,793
Income taxes recoverable367 652
Receivable from Investee65 -
2,228 2,445
Non-current assets
Investment in associate70,647 68,162
Total assets72,875 70,607
Liabilities
Current liabilities
Dividend payable1,796 1,793
Payable to investee- 457
Income taxes payable376 -
Total liabilities2,172 2,250
Equity
Common shares22,702 22,560
Contributed surplus144,819 144,819
Deficit(113,398) (115,027)
Accumulated other comprehensive income16,580 16,005
Total equity70,703 68,357
Total liabilities and equity72,875 70,607
KP Tissue Inc.
Unaudited Condensed Statements of Income (Loss)
(thousands of Canadian dollars, except share and per share amounts)
3-month
period ended
September 30, 2024
3-month
period ended
September 30, 2023
9-month
period ended
September 30, 2024
9-month
period ended
September 30, 2023
$ $ $ $
Share of income (loss)2,259 1,789 4,758 (2,909)
Depreciation of fair value increments(278) (286) (847) (886)
Equity income (loss)1,981 1,503 3,911 (3,795)
Dilution gain107 262 500 787
Income (loss) before income taxes2,088 1,765 4,411 (3,008)
Deferred tax expense - - - 3,892
Net income (loss) 2,088 1,765 4,411 (6,900)
Basic earnings (loss) per share0.21 0.18 0.44 (0.69)
Weighted average number of shares outstanding9,979,383 9,957,841 9,973,463 9,953,646
KP Tissue Inc.
Unaudited Condensed Statements of Cash Flows
(thousands of Canadian dollars)
3-month
period ended
September 30, 2024
3-month
period ended
September 30, 2023
9-month
period ended
September 30, 2024
9-month
period ended
September 30, 2023
$ $ $ $
Cash flows from (used in) operating activities
Net income (loss)2,088 1,765 4,411 (6,900)
Items not affecting cash
Equity loss (income)(1,981) (1,503) (3,911) 3,795
Dilution gain(107) (262) (500) (787)
Deferred tax expense- - - 3,892
Total items not affecting cash(2,088) (1,765) (4,411) 6,900
Decrease in payable to investee(376) (137) (660) (137)
Tax refunds, net376 137 660 137
Net cash from (used in) operating activities- - - -
Cash flows from investing activities
Dividends received, net1,743 1,739 5,239 5,242
Net cash from investing activities1,743 1,739 5,239 5,242
Cash flows used in financing activities
Dividends paid, net(1,743) (1,739) (5,239) (5,242)
Net cash used in financing activities(1,743) (1,739) (5,239) (5,242)
Increase (decrease) in cash and cash equivalents during the period- - - -
Cash and cash equivalents - Beginning of period- - - -
Cash and cash equivalents - End of period- - - -

© 2024 GlobeNewswire (Europe)
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.